• Vincamine CAS 1617-90-9 Treatment of Cerebrovascular Disease
  • Vincamine CAS 1617-90-9 Treatment of Cerebrovascular Disease
  • Vincamine CAS 1617-90-9 Treatment of Cerebrovascular Disease
  • Vincamine CAS 1617-90-9 Treatment of Cerebrovascular Disease
  • Vincamine CAS 1617-90-9 Treatment of Cerebrovascular Disease
  • Vincamine CAS 1617-90-9 Treatment of Cerebrovascular Disease

Vincamine CAS 1617-90-9 Treatment of Cerebrovascular Disease

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: White Powder
Purity: >99%
Samples:
US$ 50/Bag 1 Bag(Min.Order)
| Request Sample
Customization:
Manufacturer/Factory
Gold Member Since 2021

Suppliers with verified business licenses

Shaanxi, China
Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Experienced Team
The supplier has 6 foreign trading staff(s) and 3 staff(s) with over 6 years of overseas trading experience
Patents Awarded
The supplier had awarded 1 patents, you can check the Audit Report for more information
to see all verified strength labels (10)

Basic Info.

Appearance
White Powder
Shelf Life
2 Years
Storage
Keep in Cool and Dry Place
Delivery
Express 5-7 Days Arrive
Test Method
HPLC
Assay
99%
Shipping Area
Worldwide/All Countries
CAS
1617-90-9
Service
Good Service
Delivery Method
FedEx/DHL/Special Line
Product Name
Vincamine
Transport Package
Foil Bag
Specification
99%
Trademark
Xi′an Frazer Biotech Co., Ltd.
Origin
China
Production Capacity
200kg Per Month

Product Description

Vincamine CAS 1617-90-9 Treatment of Cerebrovascular Disease
Vincamine CAS 1617-90-9 Treatment of Cerebrovascular Disease
Vincamine CAS 1617-90-9 Treatment of Cerebrovascular Disease

Specification of Analysis

Product Name: Vincamine powder
Molecular Formula C21H26N2O3
Molecular Weight 354.44
Appearance:

White Powder

CAS  1617-90-9

Vincamine is a major alkaloid in Catharanthus roseus. It is white powder and soluble in acid solution. In
1953, schlittle and furlenmeier graduated from V Vinblastine was isolated from minor. In 1962, trojanek,
mokry and clauder determined their chemical structure. In 1968, trojanek, Blaha and others determined the
spatial configuration of vinblastine. The structure of naturally extracted vinblastine is dextral, and the synthetic
vinblastine is racemic. To some extent, vinblastine can regulate cerebral circulation, maintain neural dynamic
balance, protect nerves and resist oxidation.

Function

Vincamine is used for the prevention and treatment of cerebrovascular insufficiencies and disorders. It has been shown to be pharmacologically active in the central nervous system and in the cardiovascular system but its activity is mainly on the vessels of the brain. Other therapeutic applications of vincamine include the treatment of tinnitus and hypertension. Vincamine dietary supplements are sold in the US as "brain nutrition" to support cerebral metabolism and cognitive
function and to enhance memory and concentration.

Application                                             

1.Vincamine can be used for the treatment of psychological and behavioral disorders caused by aging.
2.It can also be used for acute cerebrovascular disease and traumatic brain injury syndrome treatment.
3.Ophthalmology aspects: for the treatment of ischemic retinal diseases.
4.Otology aspects: for the treatment of cochlea vestibular diseases.

 

What advantages of Vincamine?

1.Vincamine is a vasodilator and anti-ischemic that increases blood flow to the brain.
2.Vincamine is known primarily as a vasodilator and is in general use as a treatment for dementia.
3.Vincamine is produced through two chemical reactions beginning with the catalytic reduction of tabersonine, an alkaloid extract of Voacanga seeds.
4.Vincamine is used for the prevention and treatment of cerebrovascular insufficiencies and disorders. It has been shown to be pharmacologically active in the central nervous system and in the cardiovascular system but its activity is mainly on the vessels of the brain.

Vincamine CAS 1617-90-9 Treatment of Cerebrovascular Disease

 

 
 
 
 
 
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Registered Capital
1000000 RMB
Plant Area
501~1000 square meters